Expression of Complement Components Differs Between Kidney Allografts from Living and Deceased Donors
Maarten Naesens(KU Leuven), Minnie Sarwal(Stanford University), Poonam Sansanwal(Stanford University), Tara K. Sigdel(City College of San Francisco), Evelyne Lerut(KU Leuven), Oscar Salvatierra(Stanford University), Li Li(Unknown), Szu‐Chuan Hsieh(Stanford Medicine), Neeraja Kambham(Stanford Medicine), Lihua Ying, Atul J. Butte(University of California, San Francisco)
Cited by 133
Related Papers
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
|American Journal of Transplantation|2008|1.9k
Calcineurin Inhibitor Nephrotoxicity
|Clinical Journal of the American Society of Nephrology|2009|1.5k
Systematic pan-cancer analysis of tumour purity
|Nature Communications|2015|1.3k
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
|American Journal of Transplantation|2017|1k
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
|Nature Medicine|2011|834